Dose Insider / Analyses / The week between shots

Why the Day Before Your Shot Feels DifferentZepbound and Wegovy Levels Through the Week

Updated November 20, 2026 Β· 17 min read Β· FDA labels 2026, appetite trials

A weekly shot does not give a level dose.

44%of the weekly peak is left on the day before a Zepbound shot, by the half-life model
Left the day before the shotShare of the weekly peak, half-life modelZepbound44%Wegovy62%Left the day before the shotShare of the weekly peak, half-life modelZepbound44%Wegovy62%

On the day before a Zepbound shot, 44% of the weekly peak is left in the model.

On this page

In our model, built on the numbers in the FDA labels, Zepbound peaks about a day after the injection and falls to 44% of that peak by the time the next shot is due. Wegovy falls to 62%. The day before the shot is the lowest day of the week for both.

Whether hunger follows the level down is a separate question, and the trials answer only part of it. This page shows your own week by weekday, what a dose step and a moved shot day do to it, and what the appetite studies measured.

What does my week look like?

Pick your medicine and the day you inject. The chart runs from one shot to the next, and the list gives the level at noon on each day.

My week, day by dayModel
Medicine
Time of the shot
Right nowβ€”
Lowest pointβ€”

    Log your shots in the app and it marks where you are in the week.

    Open the app

    The level is shown as a share of the highest point of the week, once the same dose has been taken for at least four weeks. The shaded strip is the last 24 hours before the next shot. Morning is 8 am and evening is 8 pm. This is a model of the average person in the label, not a blood test.

    The table gives the same week in plain numbers, counted in days from the injection.

    Time after the shotZepboundWegovy
    1 day100%98%
    2 days89%99%
    3 days77%92%
    4 days67%84%
    5 days59%76%
    6 days51%69%
    7 days, next shot due44%62%

    Share of the weekly peak on a settled dose. Our model: one compartment, half-life 5 days and peak at 24 hours for tirzepatide, half-life 7 days and peak at 2 days for semaglutide.

    Why does the level fall during the week?

    Because the body clears the drug at a steady rate and the next dose is a week away. The measure of that rate is the half-life: the time it takes for the amount in the blood to fall by half.

    The Zepbound label gives tirzepatide a half-life of about 5 to 6 days. The Wegovy label gives semaglutide about one week.1,2 A week is therefore longer than one half-life of tirzepatide, and the level drops by more than half between its peak and the next shot. For semaglutide a week is one half-life, so the drop is smaller.

    The rise at the start of the week comes from absorption. The drug is injected under the skin and takes time to reach the blood. Tirzepatide reaches its highest level a median of 24 hours after the injection, with a range of 8 to 72 hours between people. Semaglutide reaches it 1 to 3 days after.1,2

    What the labels say
    Tirzepatide half-life5–6 days
    Semaglutide half-life1 week
    Tirzepatide peak after a shot24 hours
    Semaglutide peak after a shot1–3 days

    Each shot lands on top of what is left from the earlier ones. On a settled dose, about 44% of the Zepbound peak is still there when the next injection goes in, and most of it comes from the last shot. That is why the low point is 44% and not zero, and why one late shot does not empty the tank. The page on how long Zepbound stays in your system follows the level after the last dose.

    Which days are the low days?

    For Zepbound, the level is within a quarter of its peak for the first three days and below 60% of it from late on day five. The last day before the shot is spent under 50%.

    Part of the week spentZepboundWegovy
    At 90% of the peak or more1.5 days2.6 days
    At 75% or more3.1 days4.9 days
    At 60% or more4.8 daysAll 7
    Below 50%The last 20 hoursNever
    Average over the week72% of the peak84% of the peak

    Same model, settled dose.

    A person who injects Zepbound on Sunday morning is above 75% of the peak until Wednesday afternoon, drops under 60% early on Friday and under 50% at midday on Saturday. If Saturday is the day the week feels different, the calendar and the curve agree.

    The size of the dip does not depend on the dose. On 5 mg and on 15 mg the level falls to the same 44% of that dose's own peak. What changes with the dose is how high the whole curve sits, which is the subject of the section on dose steps.

    Why is Wegovy flatter than Zepbound?

    Its half-life is longer. With a half-life of one week and a peak that arrives on day two, semaglutide gives up 38% of its peak over the week, against 56% for tirzepatide. In the model, Wegovy never falls below 60% of its peak on a weekly schedule.

    Being flatter is not the same as being stronger. The two drugs have different doses and act on different receptors, and the percentages here compare each drug only with itself. The head-to-head page compares the two on weight loss.

    The Wegovy tablet removes the weekly wave almost entirely. It is taken once a day, and the half-life is still about a week,2 so only about 9% of the drug is cleared between one tablet and the next. The label adds that concentrations vary more from person to person with the tablet than with the injection.2

    Is the hunger before the shot the drug wearing off?

    It may be, but no trial in the labels measured appetite day by day through the week, so the link between the falling level and the hunger people describe has not been tested directly. Three things are known.

    The first is that these drugs lower food intake through appetite. Both labels say so in the same words: the drug decreases calorie intake, and the effects are likely mediated by affecting appetite.1,2

    The second is how large the effect is when it is measured in a laboratory. In a 20-week trial of 72 adults with obesity, people on semaglutide 2.4 mg ate 35% less than people on placebo at a lunch where they could eat as much as they wanted. They reported less hunger, more fullness, fewer and weaker cravings and better control of eating.3 In a 28-week study of people with type 2 diabetes, tirzepatide 15 mg and semaglutide 1 mg both reduced appetite compared with placebo, and the two did not differ from each other on appetite scores or on energy intake at the test meal.4

    The third is that the feeling fades over months even when the dose and the level stay the same. A 60-week trial of semaglutide 2.4 mg in 120 adults tested people at weeks 20, 40 and 60. At week 20 the semaglutide group reported more appetite suppression, less hunger over the past week and less preoccupation with food than the placebo group. At weeks 40 and 60 the two groups no longer differed on those ratings. They still ate less: 292, 240 and 270 kcal less at the test lunch at the three visits.5

    Semaglutide 2.4 mg against placebo, by visit
    Week 20: eaten at the test lunchβˆ’292 kcal
    Week 40βˆ’240 kcal
    Week 60βˆ’270 kcal
    Hunger ratings differ from placeboWeek 20 only

    So there are two reasons why food can feel louder before a shot, and they call for different responses. One is the weekly dip, which repeats every week and is deepest on the last day. The other is the slow return of the feeling of hunger over months, which the 60-week trial found while intake stayed down. A hunger log kept by day of the week tells the two apart: the dip shows up as a pattern tied to the shot day, the slow change does not.

    Does a higher dose lift the low days?

    It lifts the whole curve, low days included. The labels say exposure rises in proportion to the dose,1,2 so doubling the dose doubles the level at every hour of the week once the new dose has settled.

    My next dose stepModel
    Medicine
    Step
    New low pointβ€”
    Settles byβ€”

    100% is the weekly peak on the old dose, marked by the dotted line. The chart assumes the old dose had settled before the step. A dose is increased only by the prescriber, on the schedule in the label.

    The first Zepbound step is the largest in proportion. On 5 mg, the lowest point of the week sits at 89% of the old 2.5 mg peak: the worst day on the new dose is close to the best day on the old one. Later steps add less, because each adds 2.5 mg to a larger base.

    Zepbound stepNew low point, as a share of the old peak
    2.5 β†’ 5 mg89%
    5 β†’ 7.5 mg67%
    7.5 β†’ 10 mg59%
    10 β†’ 12.5 mg56%
    12.5 β†’ 15 mg53%

    Same model, both doses settled.

    Wegovy steps are larger in proportion and its week is flatter, so after the steps from 0.25 to 0.5 mg and from 0.5 to 1 mg the new low point is above the old peak, at 124% of it. From 1.7 to 2.4 mg it is 88%.

    None of this is a reason to raise a dose. The Zepbound label allows an increase after at least four weeks on the current dose and tells the prescriber to weigh the response against how well the dose is tolerated; 5 mg, 10 mg and 15 mg are all maintenance doses.1 A higher dose also brings more of the drug on the peak days. The dosing schedule page has the dates.

    Why do the first weeks feel weaker?

    For two reasons. The level has not finished building, and the starting dose is small on purpose.

    The first weeks on a doseModel
    Medicine
    Week on this dose
    This week's peakβ€”
    This week's lowβ€”

    A first course with the same dose every week. 100% is the weekly peak after the level has settled.

    Doses stack. After the first Zepbound shot the level peaks at 61% of where it will end up, then 85%, 94% and 98% after the second, third and fourth. The label says the same thing in one line: steady state is reached after four weeks of weekly dosing.1 Wegovy builds more slowly because of its longer half-life: 47%, 73%, 87% and 93% over the first four shots.

    The second reason is the dose itself. The Zepbound label calls 2.5 mg a dose for starting treatment and says it is not approved as a maintenance dose. It exists to reduce stomach and gut side effects while the body gets used to the drug.1 During those four weeks the weekly peak runs at 30%, 43%, 47% and 49% of the settled peak on 5 mg.

    The low point in the first weeks is lower too. In week one on Zepbound the level before the second shot is about a quarter of the settled peak. A first month in which the last days of the week feel like nothing is happening matches the curve. The page on the first week on Zepbound covers what the trials saw in that month.

    Can I move my shot day?

    Yes, within a limit that each label sets. The Zepbound label says the day of the weekly injection can be changed if the time between two doses is at least 3 days, or 72 hours. The Wegovy patient leaflet says the day can be changed as long as the last dose was given 2 or more days before.1,2

    Move my shot dayLabel rule and model
    Medicine

    The app moves your reminders with the shot day.

    Open the app

    The calculator counts whole days between the last shot and the new day. When the short route breaks the label's minimum gap, it shows the longer route through next week instead.

    A shorter gap stacks the new dose on a level that has not yet fallen, so the peak after it is higher than usual. A longer gap does the opposite: the level keeps falling past its usual low before the shot.

    Gap before the moved shotZepboundWegovy
    3 daysPeak 129% of usualPeak 126%
    4 daysPeak 120%Peak 119%
    5 daysPeak 113%Peak 112%
    6 daysPeak 106%Peak 106%
    8 daysLevel falls to 39% before the shot56%
    9 days34%51%
    10 days29%46%

    Same model, one moved shot on a settled dose, then weekly again. The usual low is 44% for Zepbound and 62% for Wegovy.

    The extra height fades over the following weeks. After a 5-day gap, the level before the next shot is 50% of the usual peak, against 44% in an ordinary week. Both labels raise the dose in steps to reduce stomach and gut side effects;1,2 a short gap is a brief, smaller rise of the same kind.

    Moving the day is a way to choose which days are the low ones. A person whose difficult eating days are Friday and Saturday can place the shot on Thursday, so those days fall near the peak. A person who feels sick the day after the shot may prefer the opposite and keep the peak away from a working day.

    Can I inject every five days, or split the dose?

    Neither is in the labels. Both describe one injection a week, and the 3-day and 2-day minimums are for changing the day, not for a shorter routine.1,2

    The model shows what a shorter routine would mean. One dose taken after five days instead of seven gives a peak 13% above the usual one. Repeating that every week is a higher total dose: seven doses in five weeks instead of five. The side effect rates in the labels come from weekly dosing.

    If the low days are a problem week after week, the option the labels do provide is a different maintenance dose, chosen by the prescriber.1,2

    What if the shot is late?

    The level keeps falling at the same pace. One day late, Zepbound is at 39% of its usual peak. Four days late, at the edge of the label's window, it is at 26%. Wegovy is at 56% one day late and 42% four days late.

    The labels set the limits. A missed Zepbound dose can be taken within 4 days (96 hours); after that it is skipped. A missed Wegovy injection is taken if the next scheduled dose is more than 2 days away. After two or more missed Wegovy doses in a row, the label says to restart the dose increases at a lower dose.1,2 The missed dose page turns those rules into dates.

    How can I tell if my hunger follows the curve?

    Write down a hunger score at the same time each day for three or four weeks, next to the shot day. Use one number, for example 0 to 10.

    If the scores climb in the last two days before each shot and drop after it, the pattern follows the level. That is the case where the choice of shot day matters and where a prescriber has something concrete to look at when deciding on the dose.

    If the scores have risen across the month with no weekly shape, the weekly dip is not the cause. The 60-week trial found exactly that kind of slow change in hunger ratings between week 20 and week 40, at a constant dose.5

    Does anything about me change the curve?

    Less than might be expected. The labels tested the usual suspects and found that most of them do not move the level in a way that matters.

    QuestionWhat the labels say
    Abdomen, thigh or upper arm?Similar exposure from all three sites, for both drugs
    Morning or evening, with food or without?Any time of day, with or without meals, for both drugs
    Body weight, age, sex?No clinically relevant effect on the level of tirzepatide; no clinically significant differences for semaglutide
    Kidney or liver problems?Kidney and liver impairment do not change the level of tirzepatide; no clinically significant differences for semaglutide

    Zepbound and Wegovy prescribing information, sections 2 and 12.3.1,2

    Body weight is the surprising one. A heavier person gets the same dose and, by the label, about the same level, and neither drug is dosed by weight.1,2

    The injection site does not shift the peak either, so moving from the abdomen to the thigh is not a way to smooth the week. The time of day shifts the whole curve by the same number of hours and nothing else: an evening shot moves the peak to about the next evening.

    Why does one shot last a week at all?

    Because both molecules were built to stick to albumin, a protein in the blood. Tirzepatide carries a fatty acid chain that binds it to albumin and prolongs its half-life, and 99% of the drug in the blood is bound. Semaglutide is more than 99% bound, which the label says protects it from being broken down and slows its removal by the kidneys.1,2

    Bound drug is cleared slowly. That is what stretches a single injection over a week, and it is why the level cannot be raised or lowered quickly.

    The weekly shot in numbers
    Zepbound, share reaching the blood80%
    Wegovy injection, share reaching the blood89%
    Zepbound, settled after4 weeks
    Wegovy, in the blood after the last dose5–7 weeks

    What does the model leave out?

    It describes an average person. The label gives the time to peak for tirzepatide as anywhere from 8 to 72 hours, and reports that clearance varies between people by about 20%.1 A person at one end of those ranges has an earlier peak or a shallower dip than the chart shows.

    It uses a half-life of 5 days for tirzepatide, the lower end of the label's 5 to 6 days. With 6 days the low point would be 51% of the peak, not 44%, and the weekly average 76%, not 72%.

    It tracks the amount of drug, not its effect. The Zepbound label notes that the delay in stomach emptying is largest after the first dose and diminishes over time,1 so the same level does not produce the same sensation in week one and week thirty. The semaglutide trial found no evidence of delayed stomach emptying at week 20.3

    It is a simple model: one compartment, with the absorption rate fitted to the label's time to peak. The clearance and volume figures in the label come from a more detailed population analysis.

    Short answers to common questions

    Does Zepbound wear off before the next shot?

    The level falls to about 44% of its weekly peak by the time the next shot is due, in a model built on the label. It does not reach zero: in the same model, about 2% of the peak is still there four weeks after the last dose. Whether appetite returns in step with the level has not been measured day by day.

    Which day after the shot is the level highest?

    For Zepbound, about one day after the injection: the label's median is 24 hours, with a range of 8 to 72 hours. For Wegovy, between one and three days after.

    Why am I hungrier on day six?

    By the end of day six the Zepbound level is at about half of its peak, so the timing fits. Appetite ratings also drift back over months at a constant dose, as a 60-week semaglutide trial found. A daily hunger score kept for a few weeks shows which of the two you are seeing.

    Is the dip smaller on Wegovy?

    Yes. Semaglutide's half-life is about a week, against 5 to 6 days for tirzepatide, so Wegovy falls to about 62% of its peak before the next shot and Zepbound to about 44%.

    Can I take my shot a day or two early?

    The Zepbound label allows a change of day when at least 3 days have passed since the last dose, and the Wegovy leaflet when 2 or more days have passed. A shot taken five days after the last one gives a peak about 13% higher than usual for that week.

    Does the dip go away at a higher dose?

    The dip keeps its shape: the level still falls to the same share of that dose's peak. The whole curve sits higher, so the low day on 5 mg is at 89% of the peak on 2.5 mg.

    How long until a new dose feels settled?

    About four weeks. The Zepbound label puts steady state at four weekly doses, and in the model the peak reaches 98% of its settled height by the fourth shot.

    How the calculators work

    All four calculators use one model. Each injection is absorbed and cleared at fixed rates, and the level at any hour is the sum of what is left from every earlier dose. The clearance rate comes from the label half-life: 5 days for tirzepatide and 7 days for semaglutide. The absorption rate is set so that a single dose peaks at the label's time: 24 hours for tirzepatide and 2 days for semaglutide, the middle of the label's 1 to 3 days.

    The week calculator takes a settled dose, 40 weekly shots deep, and reads the level at the hour you are in. The dose step calculator scales the new doses by the ratio of the two strengths and adds them to the fading old ones. The move calculator inserts one shot at the new gap and continues weekly from there. The first-weeks chart starts from no drug at all.

    Percentages are shares of the weekly peak on a settled dose, so they compare a drug only with itself. The figure for the Wegovy tablet is simple decay over one day at a one-week half-life, not a run of the model.

    Sources

    1. ZEPBOUND (tirzepatide) prescribing information, NDA 217806/S-041, revised August 2026. U.S. Food and Drug Administration; sections 2.1 to 2.4, 12.2 and 12.3. accessdata.fda.gov
    2. WEGOVY (semaglutide) prescribing information, NDA 215256/S-025, revised June 2026. U.S. Food and Drug Administration; sections 2.1, 2.2, 2.4, 12.2, 12.3 and the patient information. accessdata.fda.gov
    3. Friedrichsen M, Breitschaft A, Tadayon S, Wizert A, Skovgaard D. The effect of semaglutide 2.4 mg once weekly on energy intake, appetite, control of eating, and gastric emptying in adults with obesity. Diabetes Obes Metab 2021;23:754-762. doi:10.1111/dom.14280
    4. Heise T, DeVries JH, Urva S, et al. Tirzepatide reduces appetite, energy intake, and fat mass in people with type 2 diabetes. Diabetes Care 2023;46:998-1004. doi:10.2337/dc22-1710
    5. Tronieri JS, Allison KC, DeRouen K, et al. Short- and long-term effects of semaglutide 2.4 mg on energy intake, appetite, and food reward: a 60-week, double-blind randomized controlled trial. Am J Clin Nutr 2026;124:101403. doi:10.1016/j.ajcnut.2026.101403

    Related analyses

    Log each shot and how hungry you were, and see your own week against the curve.

    Open Dose Insider